Profiel
David A. Giljohann is Chief Executive Officer at EVOQ Therapeutics, Inc. since 2023.
Former roles include Founding Scientist at Aurasense LLC, Chief Operating Officer & Principal Scientist at Exicure Operating Co. from 2012 to 2013, and Chief Technology Officer at Exicure, Inc. from 2021 to 2022.
Education includes undergraduate and doctorate degrees from Northwestern University.
Actieve functies van David Giljohann
| Bedrijven | Functie | Begin |
|---|---|---|
EVOQ Therapeutics, Inc.
EVOQ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in developing new vaccine strategies for improving outcomes for cancer patients | Algemeen Directeur | 01-01-2023 |
Eerdere bekende functies van David Giljohann
| Bedrijven | Functie | Einde |
|---|---|---|
| EXICURE, INC. | Algemeen Directeur | 10-12-2021 |
Aurasense LLC
Aurasense LLC BiotechnologyHealth Technology Engages in advanced nanotechnology solutions | Hoofd Techniek/Wetenschap/O&O | 01-01-2009 |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Develops immunomodulatory and gene regulating drugs | Algemeen Directeur | - |
Opleiding van David Giljohann
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Aurasense LLC
Aurasense LLC BiotechnologyHealth Technology Engages in advanced nanotechnology solutions | Health Technology |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Develops immunomodulatory and gene regulating drugs | Health Technology |
Exicure, Inc.
Exicure, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops nucleic acid therapies against to neurological disorders and hair loss | Health Technology |
EVOQ Therapeutics, Inc.
EVOQ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in developing new vaccine strategies for improving outcomes for cancer patients | Health Technology |
















